- $34.07bn
- $33.26bn
- $5.65bn
Citi sees strong quarterly growth with likely cost impact for Resmed
Brief: Resmed Expands US Operations With New Distribution Center In Indiana
Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge
U.S. STOCKS ON THE MOVE-Church & Dwight, Tesla, Oppenheimer
U.S. STOCKS ON THE MOVE-Charter Communications, Western Digital, Regeneron
U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology
Medical device maker ResMed rises on Q2 profit beat
U.S. RESEARCH ROUNDUP-Definium Therapeutics, Kenvue, Werner Enterprises
ResMed beats quarterly profit estimates on strong demand for its sleep devices (updated)
ResMed beats quarterly profit estimates on strong demand for its sleep devices
Resmed Q2 adjusted EPS beats estimates
Brief: Resmed Q2 Adjusted EPS USD 2.81 Vs. IBES Estimate USD 2.72
What to Watch in the Day Ahead - Thursday, January 29
ResMed profit beat dampened by restructuring costs, higher expenses
Sleep apnea device maker Resmed's Q1 revenue edges past estimates on higher demand
Brief: Resmed Q1 Adjusted EPS USD 2.55 Vs. IBES Estimate USD 2.5
Brief: Resmed To Report First Quarter Fiscal 2026 Earnings On October 30, 2025
US medtech stocks fall as Trump administration opens import probe (updated)
US medtech stocks fall as Trump administration opens import probe